First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis

Reheman Adili, Michael Holinstat, K. Mast et al.|Arteriosclerosis Thrombosis and Vascular Biology|2017

Cited by 112